314. A Retrospective Review of Dalbavancin Utilization at an Academic Medical Center

BACKGROUND: Dalbavancin is a novel long-acting lipoglycopeptide with increasing utilization for management of bone and joint infections as a two-dose regimen. The purpose of this study is to describe the patient characteristics, evaluate clinical outcomes, and calculate inpatient hospital days saved...

Descripción completa

Detalles Bibliográficos
Autores principales: Napoli, Emma, Badwal, Jasmin K, Kirkpatrick, Emily R, Pinilla, Ruth Serrano, Wang, Chen-Pin, Javeri, Heta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777104/
http://dx.doi.org/10.1093/ofid/ofaa439.510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777104/
http://dx.doi.org/10.1093/ofid/ofaa439.510

Ejemplares similares